Ticker Scorecard - VTYX Basics Company: Ventyx Biosciences, Inc. IPO Date: October 21, 2021 Sector: Healthcare Industry: Biotech Market Cap: $113.84M Activated in VL: True Average Daily Range Avg Daily Range: $0.57 | 3.78% Avg Daily Range (30 D): $0.07 | 3.29% Avg Daily Range (90 D): $0.09 | 4.04% Institutional Daily Volume Avg Daily Volume: 1.03M Avg Daily Volume (30 D): 1.4M Avg Daily Volume (90 D): 1.39M Trade Size Avg Trade Size (Sh.): 123 Avg Trade Size (Sh.) (30 D): 259 Avg Trade Size (Sh.) (90 D): 220 Institutional Trades Total Inst.Trades: 1,093 Avg Inst. Trade: $1.83M Avg Inst. Trade (30 D): $1.94M Avg Inst. Trade (90 D): $1.83M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.22M Avg Closing Trade (30 D): $.63M Avg Closing Trade (90 D): $.91M Avg Closing Volume: 112.6K     News Sep 6, 2024 @ 12:00 PM Ventyx Biosciences Announces Initiation of Dosing ... Source: Ventyx Biosciences, Inc. May 16, 2024 @ 8:05 PM Ventyx Biosciences to Participate in Three Upcomin... Source: Ventyx Biosciences, Inc. May 2, 2024 @ 8:05 PM Ventyx Biosciences to Report First Quarter 2024 Fi... Source: Ventyx Biosciences, Inc. Apr 30, 2024 @ 4:00 PM What Makes Ventyx Biosciences (VTYX) a New Buy Sto... Source: Zacks Equity Research Apr 5, 2024 @ 12:01 PM Kura Sushi Posts Upbeat Sales, Joins Caribou Biosc... Source: Avi Kapoor Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.5 $-.45 $-.62 Diluted EPS $-.5 $-.45 $-.62 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -35.25M $ -31.95M $ -38.57M Operating Income / Loss $ -38.55M $ -35.71M $ -41.77M Cost of Revenue $ $ $ Net Cash Flow $ 20.65M $ -100.96M $ 90.32M PE Ratio